November 17, 2015 —
STAT News asks Dr. Collins and other experts their thoughts on germline editing. Dr. Collins warns that the ethical concerns around germline editing outweigh the minimal alleviation for human suffering this type of science could actually potentially provide. Skerrett, Patrick. STAT. Online: November 17, 2015.
October 28, 2015 —
NIH Deputy Director of Science, Outreach and Policy Kathy L. Hudson, Ph.D., and NIH Director Francis S. Collins, M.D., Ph.D., outline the revisions that will modernize the regulations known as the Common Rule that govern the ethical conduct of research involving humans. N Engl J Med; Online: October 28, 2015.
September 30, 2015 —
Eric Green, James Watson, and Francis Collins, all former directors of the National Human Genome Research Institute, write about what has happened over the past 25 years since the launch of the Human Genome Project, which changed the course of science. Nature; 526, 29-31. October 1, 2015.
September 21, 2015 —
NIH’s Chief Officer for Scientific Workforce Diversity Hannah A. Valantine, M.D., and NIH Director Francis S. Collins, M.D., Ph.D., identify cross-cutting diversity challenges ripe for scientific exploration and opportunity. Proc Natl Acad Sci USA Early Edition.
September 17, 2015 —
Reuters outlines NIH’s framework for building the Precision Medicine Initiative Cohort Program, which will seek to enroll 1 million or more participants in the largest biomedical research study ever undertaken. Steenhuysen, Julie. Reuters.
April 9, 2015 —
NIAID Director Anthony S. Fauci, M.D., and NIH Director Francis S. Collins, M.D., Ph.D., address the importance of continuing to pursue research on a global scale amid fiscal constraints. Science; 348, 6231; 159. April 9, 2015.
January 30, 2015 —
NIH Director Francis S. Collins, M.D., Ph.D. and NCI Director Harold Varmus, M.D. explain the scientific justification for the Precision Medicine Initiative in a perspective for the New England Journal of Medicine. NEJM.
January 13, 2015 —
In a JAMA Viewpoint, Dr. Collins highlights areas of research showing great promise for advancing biomedical research and technology, treatments and therapies, and improving human health. JAMA. Volume 313, Number 2.